|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.470
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.257
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.251
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.218
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.194
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.183
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.183
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.179
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.176
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.166
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.160
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.156
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.155
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.150
|
Rat |
|
|
cytokine production
|
GO:0001816 |
319 |
0.149
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.143
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.139
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.134
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.132
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.127
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.127
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.125
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.114
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.112
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.111
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.110
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.109
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.099
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.099
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.098
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.098
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.097
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.095
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.095
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.092
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.092
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.088
|
Rat |
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.087
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.087
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.087
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.086
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.083
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.083
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.082
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.081
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.081
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.080
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.078
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.078
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.075
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.075
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.073
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.073
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.073
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.071
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.071
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.069
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.068
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.068
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.068
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.067
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.067
|
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.065
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.065
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.063
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.063
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.063
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.063
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.062
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.061
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.061
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.060
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.059
|
Rat |
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.059
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.058
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.058
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.057
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.057
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.057
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.057
|
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.057
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.056
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.056
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.055
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.055
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.054
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.054
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.053
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.053
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.053
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.053
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.052
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.052
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.052
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.051
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.051
|
Rat |
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.051
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.050
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.050
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.050
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.050
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.049
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.049
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.049
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.049
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.048
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.048
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.047
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.047
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.046
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.046
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.046
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.046
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.046
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.045
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.045
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.045
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.045
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.045
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.045
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.044
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.044
|
Rat |
|
|
hexose transport
|
GO:0008645 |
56 |
0.044
|
Rat |
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.044
|
Rat |
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.044
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.044
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.043
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.043
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.043
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.042
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.042
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.042
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.041
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.041
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.041
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.041
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.040
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.040
|
Rat |
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.040
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.040
|
Rat |
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.040
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.040
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.039
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.039
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.039
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.039
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.039
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.039
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.039
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.039
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.039
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.038
|
Rat |
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.038
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.038
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.038
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.038
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.038
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.038
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.038
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.037
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.037
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.036
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.036
|
Rat |
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.036
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.036
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.035
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.035
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.035
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.034
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.034
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.034
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.034
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.034
|
|
|
|
globus pallidus development
|
GO:0021759 |
2 |
0.034
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.034
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.034
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.034
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.033
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.033
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.033
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.033
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.033
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.033
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.033
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.032
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.032
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.032
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.032
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.032
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.032
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.032
|
|
|
|
menarche
|
GO:0042696 |
1 |
0.032
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.031
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.031
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.031
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.031
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.031
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.031
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.031
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.031
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.031
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.030
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.030
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.030
|
|
|
|
type b pancreatic cell fate commitment
|
GO:0003327 |
1 |
0.030
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.030
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.030
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.030
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.030
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.030
|
Rat |
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.030
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.030
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.029
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.029
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.029
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.029
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.029
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.029
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.028
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.028
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.028
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.028
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.028
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.028
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.028
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.028
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.027
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.027
|
Rat |
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.027
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.027
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.027
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.027
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.027
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.027
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.027
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.026
|
Rat |
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.026
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.026
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.026
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.026
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.026
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.026
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.026
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.026
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.026
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.026
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.026
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.026
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.026
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.026
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.026
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.025
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.025
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.025
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.025
|
Rat |
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.025
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.025
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.025
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.025
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.025
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.025
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.024
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.024
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.024
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.024
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.024
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.024
|
|
|
|
positive regulation of fat cell proliferation
|
GO:0070346 |
1 |
0.024
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.024
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.024
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.023
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.023
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.023
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.023
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.023
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.023
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.023
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.023
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.023
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.023
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.023
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.023
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.023
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.023
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.023
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.023
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.023
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.022
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.022
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.022
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.022
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.022
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.022
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.022
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.022
|
Rat |
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.022
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.022
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.022
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.022
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.022
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.022
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.022
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.022
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.021
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.021
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.021
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.021
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.021
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.021
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.021
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.021
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.021
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.021
|
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.021
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.021
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.021
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.021
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.021
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.021
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.021
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.021
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.020
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
|
type ii pneumocyte differentiation
|
GO:0060510 |
7 |
0.020
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.020
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.020
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.020
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.020
|
Rat |
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.020
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.020
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.020
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.020
|
Rat |
|
|
connective tissue development
|
GO:0061448 |
179 |
0.020
|
|
|
|
positive regulation of activin receptor signaling pathway
|
GO:0032927 |
3 |
0.020
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.020
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.020
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.020
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.020
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.020
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.020
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.019
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.019
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.019
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.019
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.019
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.019
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.019
|
Rat |
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.019
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.019
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.019
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.019
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.019
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.019
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.019
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.019
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.019
|
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.019
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.019
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.019
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.019
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.018
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.018
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.018
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.018
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.018
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.018
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.018
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.018
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.018
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.018
|
|
|
|
positive regulation of white fat cell proliferation
|
GO:0070352 |
1 |
0.018
|
|
|
|
regulation of isoprenoid metabolic process
|
GO:0019747 |
1 |
0.018
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.018
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.018
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.018
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.018
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.018
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.018
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.018
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.018
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.018
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.018
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.018
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.018
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.017
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.017
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.017
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.017
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.017
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.017
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.017
|
Rat |
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.017
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.017
|
Rat |
|
|
trabecula formation
|
GO:0060343 |
24 |
0.017
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.017
|
Rat |
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.017
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.017
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.017
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.017
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.017
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.017
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.017
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.017
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.017
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.017
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.017
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.017
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.017
|
|
|
|
purkinje myocyte development
|
GO:0003165 |
1 |
0.017
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.017
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.017
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.017
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.017
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.017
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.016
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.016
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.016
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.016
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.016
|
|
|
|
enteroendocrine cell differentiation
|
GO:0035883 |
16 |
0.016
|
|
|
|
regulation of high voltage gated calcium channel activity
|
GO:1901841 |
2 |
0.016
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.016
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.016
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.016
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
2 |
0.016
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.016
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.016
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.016
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.016
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.016
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.016
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.016
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.016
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.015
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.015
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.015
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.015
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.015
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.015
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.015
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.015
|
|
|
|
cell cell signaling involved in lung development
|
GO:0060495 |
1 |
0.015
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.015
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.015
|
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.015
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.015
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.015
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.015
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.015
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.015
|
|
|
|
harderian gland development
|
GO:0070384 |
2 |
0.015
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.015
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.015
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.015
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.015
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.015
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.015
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.015
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.015
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.015
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.015
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.015
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.015
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.014
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.014
|
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.014
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.014
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
|
|
|
nephrogenic mesenchyme morphogenesis
|
GO:0072134 |
2 |
0.014
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.014
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.014
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.014
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.014
|
|
|
|
heart induction
|
GO:0003129 |
2 |
0.014
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.014
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.014
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.014
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.014
|
|
